SCHEMBL26536336

SCHEMBL26536336

Clc1cc(-c2ccccc2)cc(-c2cccc(-c3cccc(-c4nc5ccccc5o4)c3)c2)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.57
▸ CASP3 P42574 2/20 0.57
▸ SENP7 Q9BQF6 2/20 0.57
▸ SENP6 Q9GZR1 2/20 0.57
▸ KDM4E B2RXH2 6/20 0.50
▸ TP53 P04637 5/20 0.50
▸ HSD17B10 Q99714 4/20 0.50
▸ ALDH1A1 P00352 4/20 0.50
▸ HPGD P15428 4/20 0.50
▸ MEN1 O00255 3/20 0.50
▸ KMT2A Q03164 3/20 0.50
▸ PKM P14618 1/20 0.50
▸ MAPT P10636 4/20 0.49
▸ LMNA P02545 1/20 0.49
▸ NPC1 O15118 5/20 0.49
▸ RAB9A P51151 4/20 0.49
▸ ATM Q13315 1/20 0.49
▸ HSPD1 P10809 1/20 0.47
▸ PTPN2 P17706 1/20 0.47
▸ PTPN1 P18031 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24881978 0.94 SMN1; SMN2 (0.60) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL24881975 0.91 SMN1; SMN2 (0.60) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL16016275 0.91 ALDH1A1 (0.58) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL24557106 0.89 NPC1 (0.61) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL12376180 0.89 ALDH1A1 (0.60) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL16459336 0.88 SMN1; SMN2 (0.64) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL24155763 0.88 SMN1; SMN2 (0.58) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL12076741 0.87 ALDH1A1 (0.62) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL24881965 0.87 SMN1; SMN2 (0.63) SMN1; SMN2CASP3SENP7SENP6KDM4E
SCHEMBL19846118 0.86 ALDH1A1 (0.60) SMN1; SMN2CASP3SENP7SENP6KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322691-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2023-10-12 — — US disclosed
US-20230322691-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CANON KABUSHIKI KAISHA (JP) 2023-10-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322691-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT CCNT1, CCNE2, SCO2 SMN1; SMN2 1253/4885CASP3 3390/4885SENP7 4713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback